Global cancer research in the post-pandemic world

COVID-19 and Cancer Task Force

doi:10.1016/S1470-2045(21)00602-1

Global cancer research in the post-pandemic world

COVID-19 and Cancer Task Force

Research output: Contribution to journal › Comment/debate › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	1652-1654
Number of pages	3
Journal	The Lancet Oncology
Volume	22
Issue number	12
DOIs	https://doi.org/10.1016/S1470-2045(21)00602-1
Publication status	Published - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1470-2045(21)00602-1

Cite this

@article{a6e74b2ed9b545e8b2ac9fac2e59e46a,

title = "Global cancer research in the post-pandemic world",

author = "{COVID-19 and Cancer Task Force} and Deborah Mukherji and Murillo, {Raul Hernando} and {Van Hemelrijck}, Mieke and Verna Vanderpuye and Omar Shamieh and Julie Torode and Pramesh, {C. S.} and Aasim Yusuf and Booth, {Chris M.} and Ajay Aggarwal and Richard Sullivan",

note = "Funding Information: DM reports institutional research grants from Astellas and Bristol Myers Squibb; and honoraria for educational events from Astellas, Bayer, Janssen, Merck Sharpe and Dohme, Bristol Myers Squibb, and AstraZeneca. All other authors declare no competing interests. The COVID-19 and Cancer Task Force receives funding from the UK Research and Innovation as part of the Global Challenges Research Fund; Research for Health in Conflict in the Middle East and North Africa (R4HC-MENA) project (grant number ES/P010962/1). The funding agency has no role in the writing of the manuscript or decision to submit it for publication.",

year = "2021",

month = dec,

doi = "10.1016/S1470-2045(21)00602-1",

language = "English",

volume = "22",

pages = "1652--1654",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "12",

}

TY - JOUR

T1 - Global cancer research in the post-pandemic world

AU - COVID-19 and Cancer Task Force

AU - Mukherji, Deborah

AU - Murillo, Raul Hernando

AU - Van Hemelrijck, Mieke

AU - Vanderpuye, Verna

AU - Shamieh, Omar

AU - Torode, Julie

AU - Pramesh, C. S.

AU - Yusuf, Aasim

AU - Booth, Chris M.

AU - Aggarwal, Ajay

AU - Sullivan, Richard

N1 - Funding Information: DM reports institutional research grants from Astellas and Bristol Myers Squibb; and honoraria for educational events from Astellas, Bayer, Janssen, Merck Sharpe and Dohme, Bristol Myers Squibb, and AstraZeneca. All other authors declare no competing interests. The COVID-19 and Cancer Task Force receives funding from the UK Research and Innovation as part of the Global Challenges Research Fund; Research for Health in Conflict in the Middle East and North Africa (R4HC-MENA) project (grant number ES/P010962/1). The funding agency has no role in the writing of the manuscript or decision to submit it for publication.

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85120347458&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(21)00602-1

DO - 10.1016/S1470-2045(21)00602-1

M3 - Comment/debate

AN - SCOPUS:85120347458

SN - 1470-2045

VL - 22

SP - 1652

EP - 1654

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 12

ER -

Global cancer research in the post-pandemic world

UN SDGs

Access to Document

Other files and links

Cite this